SLBT
SL Science Holding Limited Ordinary Shares
NASDAQ · Healthcare · Biotechnology · US
$1.11
−9.02%Margins
Gross margin
35.3%
EBITDA margin
-170.4%
EBIT margin
-174.6%
Net margin
-173.8%
FCF margin
-101.5%
-80.7%
Return on equity
-66.0%
Return on assets
-76.2%
Return on invested capital
0.38x
Asset turnover
-$1.9M
Cash from operations
$0.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025